© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 44.48% of PHGE shares are held by financial institutions. CAROLINA WEALTH ADVISORS, LLC is the top corporate investor, holding 159 shares valued at $83.00. A 0% stake in BiomX Inc. is owned by the company. JOHNSON & JOHNSON owns 96.87K shares valued at $50.86K, which translates its holding of 0.31% of the stake in the company.
| Date | Holder | % Stake | Shares Held | Total Value ($) | Shares | % Change in Portfolio |
|---|---|---|---|---|---|---|
| Sep 30, 2025 | CAROLINA WEALTH ADVISORS, LLC | 0% | 159 | 83 | 0 | 0 |
| Sep 30, 2025 | JOHNSON & JOHNSON | 0.31% | 96.87K | 50.86K | 0 | 0 |
| Jun 30, 2025 | CAROLINA WEALTH ADVISORS, LLC | 0% | 159 | 72 | 0 | 0 |
| Jun 30, 2025 | JOHNSON & JOHNSON | 0.42% | 96.87K | 42.62K | 0 | 0 |
| Mar 31, 2025 | JOHNSON & JOHNSON | 0.14% | 96.87K | 53.83K | 0 | 0 |
| Mar 31, 2025 | CAROLINA WEALTH ADVISORS, LLC | 0% | 159 | 88 | 159 | +100.00% |
| Mar 31, 2024 | XTX TOPCO LTD | 0.02% | 10.19K | 4.59K | -4.34K | -29.89% |
| Mar 31, 2024 | UBS GROUP AG | 0% | 0 | - | -2K | -100.00% |
| Mar 31, 2024 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11.9% | 6.11M | 2.75M | 6.11M | +100.00% |
| Mar 31, 2024 | ORBIMED ADVISORS LLC | 8.8% | 4.52M | 2.03M | 0 | 0 |
| Mar 31, 2024 | MILLENNIUM MANAGEMENT LLC | 0.04% | 19.76K | 8.89K | 19.76K | +100.00% |
| Mar 31, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | 0.01% | 4K | 1.8K | 0 | 0 |
| Mar 31, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0% | 0 | - | -49.5K | -100.00% |
| Mar 31, 2024 | WALLEYE CAPITAL LLC | 0% | 0 | - | -21.06K | -100.00% |
| Mar 31, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0% | 0 | - | -10.91K | -100.00% |
| Mar 31, 2024 | CITADEL ADVISORS LLC | 0% | 0 | - | -33.58K | -100.00% |
| Mar 31, 2024 | 8VC GP I, LLC | 2.12% | 1.09M | 488.79K | 0 | 0 |
| Mar 31, 2024 | WALLEYE TRADING LLC | 0% | 0 | - | -10.42K | -100.00% |
| Mar 31, 2024 | MMCAP INTERNATIONAL INC. SPC | 0% | 0 | - | -96.81K | -100.00% |
| Mar 31, 2024 | IKARIAN CAPITAL, LLC | 21.07% | 10.82M | 4.87M | 10.82M | +100.00% |
| Mar 31, 2024 | JOHNSON & JOHNSON | 3.75% | 1.92M | 865.44K | -210.2K | -9.85% |
| Mar 31, 2024 | RENAISSANCE TECHNOLOGIES LLC | 0.16% | 80.6K | 36K | -29.69K | -26.92% |
| Mar 31, 2024 | JUMP FINANCIAL, LLC | 0.04% | 19.21K | 8.64K | 19.21K | +100.00% |
| Dec 31, 2023 | MILLENNIUM MANAGEMENT LLC | 0% | 0 | - | -23.35K | -100.00% |
| Dec 31, 2023 | JOHNSON & JOHNSON | 3.52% | 2.13M | 597.35K | 0 | 0 |
| Dec 31, 2023 | 1.79% | 1.09M | 304.13K | 1.09M | +100.00% | |
| Dec 31, 2023 | RENAISSANCE TECHNOLOGIES LLC | 0.18% | 110.29K | 31K | -34.33K | -23.74% |
| Dec 31, 2023 | MMCAP INTERNATIONAL INC. SPC | 0.16% | 96.81K | 26.33K | -415.7K | -81.11% |
| Dec 31, 2023 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.08% | 49.5K | 13.86K | 0 | 0 |
| Dec 31, 2023 | CITADEL ADVISORS LLC | 0.06% | 33.58K | 9.4K | 33.58K | +100.00% |
| Dec 31, 2023 | WALLEYE CAPITAL LLC | 0.03% | 21.06K | 5.9K | 0 | 0 |
| Dec 31, 2023 | XTX TOPCO LTD | 0.02% | 14.53K | 4.07K | 14.53K | +100.00% |
| Dec 31, 2023 | WALLEYE TRADING LLC | 0.02% | 10.42K | 2.92K | 0 | 0 |
| Dec 31, 2023 | PNC FINANCIAL SERVICES GROUP, INC. | 0.01% | 4K | 1.12K | 0 | 0 |
| Dec 31, 2023 | UBS GROUP AG | 0% | 2K | 560 | 1.9K | +1,823.08% |
| Dec 31, 2023 | ORBIMED ADVISORS LLC | 7.46% | 4.52M | 1.26M | -35.9K | -0.79% |
| Sep 30, 2023 | VIRTU FINANCIAL LLC | 0% | 0 | - | -54.03K | -100.00% |
| Sep 30, 2023 | J. GOLDMAN & CO LP | 0% | 0 | - | -150K | -100.00% |
| Sep 30, 2023 | UBS GROUP AG | 0% | 104 | 37 | 104 | +100.00% |
| Sep 30, 2023 | PNC FINANCIAL SERVICES GROUP, INC. | 0.01% | 4K | 1.41K | 4K | +100.00% |
| Sep 30, 2023 | WALLEYE TRADING LLC | 0.02% | 10.42K | 3.67K | 0 | 0 |
| Sep 30, 2023 | WALLEYE CAPITAL LLC | 0.04% | 21.06K | 7.41K | 0 | 0 |
| Sep 30, 2023 | MILLENNIUM MANAGEMENT LLC | 0.05% | 23.35K | 8.22K | -22.5K | -49.07% |
| Sep 30, 2023 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.1% | 49.5K | 17.42K | 0 | 0 |
| Sep 30, 2023 | RENAISSANCE TECHNOLOGIES LLC | 0.28% | 144.63K | 51K | -50.87K | -26.02% |
| Sep 30, 2023 | MMCAP INTERNATIONAL INC. SPC | 0.99% | 512.5K | 180.4K | -131.95K | -20.47% |
| Sep 30, 2023 | JOHNSON & JOHNSON | 4.14% | 2.13M | 750.96K | 0 | 0 |
| Sep 30, 2023 | ORBIMED ADVISORS LLC | 8.83% | 4.55M | 1.6M | 0 | 0 |
Among the PHGE insiders holding of 18.81% of the stake in company, ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP, 10 percent owner, holds the largest shares of 13.77M. UGWUMBA CHIDOZIE, director, is the second largest PHGE insider with ownership of 3M shares. CHIMOVITS EREZ, , stands third with possession of 2.31M shares of that stake.
| Insiders | Designation | Shares Held |
|---|---|---|
| ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 10 percent owner | 13.77M |
| UGWUMBA CHIDOZIE | director | 3M |
| CHIMOVITS EREZ | 2.31M | |
| GROSSMAN JONAS | director | 28.13K |
| AMUSA GBOLAHAN | director | 18.75K |
| SOLOMON JONATHAN EITAN | Chief Executive Officer | 18.75K |
| SEKHRI PAUL J | director | 9.38K |
| SULLIVAN LYNNE MARIE | director | 9.38K |
| MOSES ALAN CHARLES | director | 3.75K |
| WOLFSON MARINA | SVP of Finance & Operations | 2.81K |
| GREIG RUSSELL | director | 2.81K |
| ORON ASSAF | Chief Business Officer | 0 |
| Date | Insider | Type | Cost | Shares | Value ($) | Shares Total |
|---|---|---|---|---|---|---|
| May 15, 2024 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | SALE | 0.38 | 24.34K | 9.28K | 13.77M |
| Mar 15, 2024 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 0.00 | 4.33K | - | 4.33K |
| Nov 29, 2023 | ORON ASSAF | SALE | 0.34 | 2.06K | 699.04 | 0 |
| May 22, 2023 | ORON ASSAF | PURCHASE | 0.27 | 3.19K | 871.74 | 10.91K |
| May 19, 2023 | ORON ASSAF | PURCHASE | 0.28 | 6.52K | 1.83K | 7.72K |
| May 18, 2023 | ORON ASSAF | PURCHASE | 0.27 | 1.2K | 327.51 | 1.2K |
| Feb 27, 2023 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 0.24 | 1.79M | 436.75K | 1.79M |
| Nov 04, 2022 | UGWUMBA CHIDOZIE | SALE | 0.38 | 1.5K | 567.38 | 3M |
| Nov 03, 2022 | UGWUMBA CHIDOZIE | SALE | 0.37 | 2K | 732 | 3M |
| Nov 02, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 2.42K | 867.34 | 3M |
| Nov 01, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 1.3K | 473.2 | 3M |
| Oct 31, 2022 | UGWUMBA CHIDOZIE | SALE | 0.37 | 3.3K | 1.22K | 3M |
| Oct 28, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 1.53K | 543.26 | 3.01M |
| Oct 27, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 1.51K | 547.82 | 3.01M |
| Oct 26, 2022 | UGWUMBA CHIDOZIE | SALE | 0.35 | 12.5K | 4.33K | 3.01M |
| Oct 25, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 3.07K | 1.12K | 3.02M |
| Oct 24, 2022 | UGWUMBA CHIDOZIE | SALE | 0.35 | 5.9K | 2.06K | 3.03M |
| Oct 21, 2022 | UGWUMBA CHIDOZIE | SALE | 0.37 | 5.4K | 2K | 3.03M |
| Oct 20, 2022 | UGWUMBA CHIDOZIE | SALE | 0.37 | 6.64K | 2.48K | 3.04M |
| Oct 19, 2022 | UGWUMBA CHIDOZIE | SALE | 0.37 | 4.5K | 1.65K | 3.04M |
| Oct 18, 2022 | UGWUMBA CHIDOZIE | SALE | 0.35 | 15.3K | 5.29K | 3.05M |
| Oct 17, 2022 | UGWUMBA CHIDOZIE | SALE | 0.34 | 8.1K | 2.71K | 3.06M |
| Oct 14, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 3.42K | 1.13K | 3.07M |
| Oct 13, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 11.31K | 3.73K | 3.08M |
| Oct 12, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 9.7K | 3.23K | 3.09M |
| Oct 11, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 5.99K | 1.99K | 3.1M |
| Oct 10, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 10.04K | 3.27K | 3.1M |
| Oct 07, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 24.71K | 8.85K | 3.11M |
| Oct 06, 2022 | UGWUMBA CHIDOZIE | SALE | 0.44 | 25.1K | 11.14K | 3.14M |
| Oct 05, 2022 | UGWUMBA CHIDOZIE | SALE | 0.43 | 46.79K | 20.35K | 3.16M |
| Oct 04, 2022 | UGWUMBA CHIDOZIE | SALE | 0.34 | 19.2K | 6.6K | 3.21M |
| Oct 03, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 15.02K | 4.96K | 3.23M |
| Sep 30, 2022 | UGWUMBA CHIDOZIE | SALE | 0.36 | 8.66K | 3.08K | 3.24M |
| Sep 29, 2022 | UGWUMBA CHIDOZIE | SALE | 0.35 | 3.3K | 1.15K | 3.25M |
| Sep 28, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 15.65K | 5.21K | 3.26M |
| Sep 27, 2022 | UGWUMBA CHIDOZIE | SALE | 0.33 | 4.87K | 1.61K | 3.27M |
| Sep 26, 2022 | UGWUMBA CHIDOZIE | SALE | 0.35 | 17.53K | 6.22K | 3.28M |
| Sep 23, 2022 | UGWUMBA CHIDOZIE | SALE | 0.37 | 5.31K | 1.98K | 3.29M |
| Sep 22, 2022 | UGWUMBA CHIDOZIE | SALE | 0.41 | 17.39K | 7.18K | 3.3M |
| Sep 21, 2022 | UGWUMBA CHIDOZIE | SALE | 0.43 | 5.57K | 2.38K | 3.32M |
| Sep 20, 2022 | UGWUMBA CHIDOZIE | SALE | 0.45 | 10.63K | 4.79K | 3.32M |
| Sep 19, 2022 | UGWUMBA CHIDOZIE | SALE | 0.48 | 13.87K | 6.73K | 3.33M |
| Sep 16, 2022 | UGWUMBA CHIDOZIE | SALE | 0.51 | 3.2K | 1.64K | 3.35M |
| Sep 15, 2022 | UGWUMBA CHIDOZIE | SALE | 0.53 | 3.9K | 2.07K | 3.35M |
| Sep 14, 2022 | UGWUMBA CHIDOZIE | SALE | 0.52 | 2.3K | 1.2K | 3.35M |
| Sep 13, 2022 | UGWUMBA CHIDOZIE | SALE | 0.53 | 2.2K | 1.16K | 3.34M |
| Sep 12, 2022 | UGWUMBA CHIDOZIE | SALE | 0.54 | 1.7K | 919.7 | 3.36M |
| Sep 09, 2022 | UGWUMBA CHIDOZIE | SALE | 0.52 | 13.22K | 6.85K | 3.36M |
| Sep 08, 2022 | UGWUMBA CHIDOZIE | SALE | 0.52 | 4.59K | 2.4K | 3.37M |
| Sep 07, 2022 | UGWUMBA CHIDOZIE | SALE | 0.53 | 8.85K | 4.67K | 3.38M |
| Sep 06, 2022 | UGWUMBA CHIDOZIE | SALE | 0.55 | 6.4K | 3.49K | 3.39M |
| Sep 02, 2022 | UGWUMBA CHIDOZIE | SALE | 0.55 | 2K | 1.09K | 3.39M |
| Sep 01, 2022 | UGWUMBA CHIDOZIE | SALE | 0.55 | 8.3K | 4.53K | 3.39M |
| Aug 31, 2022 | UGWUMBA CHIDOZIE | SALE | 0.55 | 4.54K | 2.49K | 3.4M |
| Aug 30, 2022 | UGWUMBA CHIDOZIE | SALE | 0.57 | 13.49K | 7.63K | 3.41M |
| Aug 29, 2022 | UGWUMBA CHIDOZIE | SALE | 0.57 | 11.53K | 6.59K | 3.42M |
| Aug 26, 2022 | UGWUMBA CHIDOZIE | SALE | 0.62 | 60.63K | 37.35K | 3.43M |
| Aug 25, 2022 | UGWUMBA CHIDOZIE | SALE | 0.72 | 26.95K | 19.35K | 3.49M |
| Aug 24, 2022 | UGWUMBA CHIDOZIE | SALE | 0.65 | 8.67K | 5.65K | 3.52M |
| Aug 23, 2022 | UGWUMBA CHIDOZIE | SALE | 0.64 | 5.9K | 3.76K | 3.53M |
| Aug 22, 2022 | UGWUMBA CHIDOZIE | SALE | 0.66 | 5K | 3.29K | 3.53M |
| Aug 19, 2022 | UGWUMBA CHIDOZIE | SALE | 0.64 | 14.6K | 9.33K | 3.54M |
| Aug 18, 2022 | UGWUMBA CHIDOZIE | SALE | 0.68 | 7.76K | 5.3K | 3.55M |
| Aug 17, 2022 | UGWUMBA CHIDOZIE | SALE | 0.69 | 21.34K | 14.68K | 3.56M |
| Aug 16, 2022 | UGWUMBA CHIDOZIE | SALE | 0.73 | 8.56K | 6.24K | 3.58M |
| Aug 15, 2022 | UGWUMBA CHIDOZIE | SALE | 0.75 | 7.2K | 5.38K | 3.59M |
| Aug 12, 2022 | UGWUMBA CHIDOZIE | SALE | 0.73 | 11.41K | 8.37K | 3.6M |
| Aug 11, 2022 | UGWUMBA CHIDOZIE | SALE | 0.74 | 9.82K | 7.31K | 3.61M |
| Aug 10, 2022 | UGWUMBA CHIDOZIE | SALE | 0.74 | 17.77K | 13.15K | 3.62M |
| Jul 28, 2021 | GREIG RUSSELL | PURCHASE | 5.00 | 2.81K | 14.07K | 2.81K |
| Jul 28, 2021 | WOLFSON MARINA | PURCHASE | 5.00 | 2.81K | 14.07K | 2.81K |
| Jul 28, 2021 | SEKHRI PAUL J | PURCHASE | 5.00 | 9.38K | 46.88K | 9.38K |
| Jul 28, 2021 | MOSES ALAN CHARLES | PURCHASE | 5.00 | 3.75K | 18.75K | 3.75K |
| Jul 28, 2021 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 5.00 | 375K | 1.88M | 375K |
| Jul 28, 2021 | SULLIVAN LYNNE MARIE | PURCHASE | 5.00 | 9.38K | 46.88K | 9.38K |
| Jul 28, 2021 | SOLOMON JONATHAN EITAN | PURCHASE | 5.00 | 18.75K | 93.75K | 18.75K |
| Jul 26, 2021 | GROSSMAN JONAS | PURCHASE | 5.00 | 28.13K | 140.63K | 28.13K |
| Jul 26, 2021 | AMUSA GBOLAHAN | PURCHASE | 5.00 | 18.75K | 93.75K | 18.75K |
| Jul 26, 2020 | GROSSMAN JONAS | PURCHASE | 5.00 | 28.13K | 140.63K | 28.13K |
| Dec 19, 2019 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 8.90 | 3.5K | 31.15K | 2.31M |
| Dec 19, 2019 | CHIMOVITS EREZ | PURCHASE | 8.90 | 3.5K | 31.15K | 2.31M |
| Dec 18, 2019 | CHIMOVITS EREZ | PURCHASE | 8.93 | 500 | 4.47K | 2.31M |
| Dec 18, 2019 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 8.93 | 500 | 4.47K | 2.31M |
| Dec 11, 2019 | CHIMOVITS EREZ | PURCHASE | 8.92 | 5.4K | 48.17K | 2.31M |
| Dec 11, 2019 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 8.92 | 5.4K | 48.17K | 2.31M |
| Dec 10, 2019 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | PURCHASE | 8.75 | 3.4K | 29.75K | 2.3M |
| Dec 10, 2019 | CHIMOVITS EREZ | PURCHASE | 8.75 | 3.4K | 29.75K | 2.3M |